Research for treatments, prevention and a cure
Page template: single-clinical-trials.php
Search terms : 

Clinical Trials

  • Clinical Studies

Clinical Care and Management (CCM)

CTN 315: The KIND Study

Kids Imaging and Neurocognitive Development Study

Print Friendly, PDF & Email

About the study (objectives)

Thanks to advances in treatment, many women living with HIV can get pregnant with minimal risk of giving birth to a child who has the virus. While most children who are HIV-exposed but uninfected (CHEU) are in good health, it is unclear how exposure to HIV and antiretroviral therapy (ART) during pregnancy could impact their brain development and long-term health.

CTN 315 aims to examine brain development and long-term behavioural and cognitive function of CHEU by comparing brain structure and function between CHEU and children who are HIV-unexposed and uninfected (CHUU). The study hopes to address clinically important knowledge gaps that affect the long-term health of CHEU.

About the disease/condition (background/context)

In Canada, 200-300 babies are born to women living with HIV each year, and almost all of these children are HIV-negative despite exposure to the virus, thanks to ART and transmission prevention programs. A number of observational studies suggest that HEU children may have a higher risk of health issues such as increased morbidity and mortality in the first year of life, higher likelihood of pre-term birth, increased risk of infection, and mental health impairments. The increasing number of CHEU could result in more instances of health issues, impacting on public health and the CHEU’s ability to reach their full potential.

Study Approach (methodology)

This multi-site prospective clinical study will conduct cognitive, behavioural, and brain imaging (MRI and MR spectroscopy) investigations of 180 CHEU and 65 CHUU to better characterize overall brain function and explore links between brain function and behavioural deficits and changes in specific brain regions.

Eligibility criteria

Inclusion criteria:

For CHEU participants

  • Aged 6-10 years at time of enrolment
  • Mother was living with HIV during pregnancy
  • Mother was on ART for at least 4 weeks during pregnancy

For CHUU participants

  • Aged 6-10 years at time of enrolment
  • Mother who was HIV-negative during pregnancy

Exclusion criteria:

  • Presence of braces or other metal implants that would be prohibitive to MRI
  • Previous developmental or neurological condition unrelated to HIV/ART exposure (e.g. stroke, Trisomy 21) with residual function
  • For CHEU participants: Those diagnosed with autism spectrum disorder (ASD) and attention-deficit hyperactivity disorder (ADHD) can participate in the study
  • For CHUU participants: Those diagnosed with autism spectrum disorder (ASD) and attention-deficit hyperactivity disorder (ADHD) cannot participate in the study
  • Significant maternal smoking, regular alcohol consumption, or use of illicit drugs during pregnancy that are known to influence the unborn child’s brain development (e.g. cocaine use)

Participating Sites


Hospital for Sick Children
Dr. Ari Bitnun
555 University Avenue
Toronto, Ontario
Phone: 416-813-6268

Study Coordinator
Cheryl Arneson


Children’s Hospital of Eastern Ontario (CHEO)
Dr. Jason Brophy
401 Smyth Road
Ottawa, Ontario
Phone: 613-737-7600 x2651

Study Coordinator
Jen Bowes

Additional Information

For more information about the study, please contact the principal investigator.

Principal Investigator

Dr. Lena Serghides
University Health Network
Princess Margaret Cancer Research Tower
101 College Street, Room 10-359
Toronto, Ontario
Phone: 416-634-8175

Latest News

A collaborative approach to women-centred HIV care

| Uncategorized | No Comments

Many HIV-specific services are not designed or delivered with women in mind. In response, the CHIWOS team developed two toolkits to bring holistic care to women living with HIV, both launching July 8, 2020

The CTN at AIDS 2020: Virtual

| Uncategorized | No Comments

AIDS 2020: Virtual is almost here. Across July 6-10, you can access prime sessions, workshops, symposia, abstract sessions, pre-conferences, and satellite sessions, each showcasing some of the latest research in the HIV field.

CTN at CAHR 2020

| Uncategorized | No Comments

The 29th Annual Canadian Conference on HIV/AIDS Research (CAHR 2020) will take place May 1-2 and, this year, it’s going virtual

Darren Lauscher, Comité consultatif auprès de la communauté (CCC) du Réseau

Voices from the Community: people living with HIV weigh in on COVID-19

| Uncategorized | No Comments

As we settle into a new normal during the COVID-19 pandemic, it’s easy to feel like we are in uncharted territory. But for people living with HIV, they’ve seen this all before

Research for treatments, prevention and a cure